SCHEMBL14008995

SCHEMBL14008995

Cc1ccccc1NC(=O)c1ccc(C(=O)Nc2ccc(-n3cncn3)cc2)o1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 2/20 0.53
▸ POLB P06746 1/20 0.53
▸ APOBEC3A P31941 1/20 0.48
▸ APOBEC3G Q9HC16 1/20 0.48
▸ LMNA P02545 1/20 0.46
▸ ROCK1 Q13464 1/20 0.46
▸ KMT2A Q03164 2/20 0.44
▸ S1PR4 O95977 1/20 0.44
▸ DDX3X O00571 3/20 0.43
▸ RAB9A P51151 2/20 0.43
▸ NPC1 O15118 1/20 0.43
▸ TP53 P04637 1/20 0.43
▸ GAA P10253 1/20 0.43
▸ KLK7 P49862 1/20 0.42
▸ GALK1 P51570 1/20 0.42
▸ ALDH1A1 P00352 1/20 0.42
▸ MAPT P10636 1/20 0.42
▸ HPGD P15428 1/20 0.42
▸ MEN1 O00255 1/20 0.41
▸ MITF O75030 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14009058 0.87 ROCK1 (0.51) KDM4EPOLBAPOBEC3AAPOBEC3GLMNA
SCHEMBL14009001 0.85 KDM4E (0.53) KDM4EPOLBLMNAROCK1KMT2A
SCHEMBL14009031 0.84 S1PR4 (0.51) APOBEC3AAPOBEC3GLMNAKMT2AS1PR4
SCHEMBL14009228 0.83 TYK2 (0.46) KDM4EPOLBAPOBEC3AAPOBEC3GLMNA
SCHEMBL14009076 0.83 HTT (0.53) KDM4EAPOBEC3AAPOBEC3GLMNAROCK1
SCHEMBL14009028 0.81 MAPT (0.55) KDM4EPOLBLMNAKMT2ARAB9A
SCHEMBL14009299 0.78 ROCK1 (0.52) KDM4EPOLBLMNAROCK1KMT2A
SCHEMBL14008956 0.75 SMYD3 (0.48) KDM4ELMNAKMT2ARAB9ANPC1
SCHEMBL14009275 0.74 MEN1 (0.50) KDM4EAPOBEC3AAPOBEC3GLMNAROCK1
SCHEMBL14009351 0.74 RAB9A (0.42) KDM4EPOLBAPOBEC3AAPOBEC3GROCK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7446195-B2 High affinity thiophene-based and furan-based kinase ligands SCHERING CORPORATION (US) 2008-11-04 — — US disclosed
US-7446195-B2 High affinity thiophene-based and furan-based kinase ligands SCHERING CORPORATION (US) 2008-11-04 — — US disclosed
US-20070043045-A1 Novel high affinity thiophene-based and furan-based kinase ligands SCHERING CORPORATION 2007-02-22 — — US disclosed
US-20070043045-A1 Novel high affinity thiophene-based and furan-based kinase ligands SCHERING CORPORATION 2007-02-22 — — US disclosed
WO-2007022258-A1 NOVEL HIGH AFFINITY THIOPHENE-BASED AND FURAN-BASED KINASE LIGANDS SCHERING CORPORATION (US) 2007-02-22 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070043045-A1 Novel high affinity thiophene-based and furan-based kinase ligands CDKL2, CDK2, CDKL1 KDM4E 638/4885POLB 1045/4885APOBEC3A 3662/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback